Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 11:34 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2569–2592 of 3,569 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: self-control Clear all

Conditions: Vasectomy
Interventions: Nitrous Oxide, Oxygen; Drug
Lead sponsor: Alexandra J. Berger Eberhardt, MD; Other
Eligibility: 18 Years to 85 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alcohol Consumption, Fetal Alcohol Syndrome Disorders, Students
Interventions: Self-guided Motivational Intervention, Informational Only; Behavioral
Lead sponsor: Nova Southeastern University; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 354 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Fort Lauderdale, Florida

Conditions: Migraine
Interventions: MRI, Thermal Stimuli, Pressure stimuli, Pain ratings, Pressure pain thresholds (PPT), Conditioned pain modulation (CPM) efficiency, Hormonal assessment, Migraine-related measures, Neural assessments, Pubertal status; Device · Behavioral · Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 10 Years to 13 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Alcohol-Related Disorders, Alcohol Use Disorders, Alcohol Drinking, Alcoholism, Alcohol Abuse
Interventions: Full Motivational Interviewing ("FMI"), Spirit Only Motivational Interviewing ("SOMI"); Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Great Neck, New York

Conditions: Family Research
Interventions: FSI-R Treatment; Behavioral
Lead sponsor: Boston College; Other
Eligibility: 7 Years and older
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: Lewiston, Maine • Springfield, Massachusetts

Conditions: Overweight, Weight Loss, Obese
Interventions: Attends with partner, Couples Skill Training, Face to face group sessions, Self Monitor, Notebook, Feedback; Behavioral · Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Young Adult, Cancer, Physical Activity
Interventions: Step-Up Intervention; Behavioral
Lead sponsor: University of Wisconsin, Milwaukee; Other
Eligibility: 18 Years to 39 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Milwaukee, Wisconsin

Conditions: Contraception
Interventions: Video + Prompt Card, Decision Aids + Training; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 15 Years to 49 Years
Enrollment: 5,038 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Prematurity, VLBW - Very Low Birth Weight Infant
Interventions: Prepod, Joint compression exercises; Other · Procedure
Lead sponsor: Asante Health System; Other
Eligibility: 32 Weeks to 36 Weeks
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Medford, Oregon

Conditions: Fertility Risk
Interventions: Subsidy for fertility consult, Invitation to purchase fertility consult; Other
Lead sponsor: Turtle Health, Inc.; Industry
Eligibility: 25 Years to 35 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Smoking, Cigarette, Smoking Cessation, Stress, Stress, Emotional, Stress Reaction
Interventions: heart rate variability biofeedback and cognitive reappraisal, control tasks; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Self-regulation, Medication Adherence
Interventions: Self-Regulation Intervention; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 13 Years to 17 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Autism Spectrum Disorder
Interventions: Pathways Intervention, Parent Education Intervention (PEI); Behavioral
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 12 Months to 42 Months
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Nicotine Use Disorder
Interventions: Realtime biofeedback using fMRI; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: Polysomnography (PSG), Rectal thermistor 400 Series, Bright blue-green light, Dim red light, Digital foot candle datalogging light meter, Patient-Reported Outcomes Measurement Information System (PROMIS)-Cancer-Fatigue, Patient-Reported Outcomes Measurement Information System (PROMIS)-Sleep Disturbance, Patient-Reported Outcomes Measurement Information System (PROMIS)-Depression, Patient-Reported Outcomes Measurement Information System (PROMIS)-Physical Function, Pittsburgh Sleep Quality Index (PSQI), Center for Epidemiological Studies - Depression, Montreal Cognitive Assessment (MoCA), European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire (EORTC QLQ-C30), Daily Log; Diagnostic Test · Other
Lead sponsor: Michigan State University; Other
Eligibility: 21 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Diabetes Mellitus, Type 1
Interventions: Share plus intervention, Control group; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 60 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Breast Neoplasms, Musculoskeletal Pain
Interventions: Hypnosis, Attention Control; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older · Female only
Enrollment: 191 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Type 2 Diabetes Mellitus
Interventions: SAR425899, Placebo, Liraglutide, Metformin; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 296 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 23
States / cities: Sheffield, Alabama • Huntington Park, California • Los Angeles, California + 18 more

Conditions: Type 2 Diabetes Mellitus
Interventions: Insulin Glargine (HOE901 - U300), Insulin Glargine (HOE901 - U100), Background therapy; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 65 Years and older
Enrollment: 1,014 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 64
States / cities: Saraland, Alabama • Fresno, California • Greenbrae, California + 57 more

Conditions: Aphasia, Acquired, Language Disorders, Primary Progressive Aphasia, Stroke, Cerebrovascular
Interventions: individualized speech-language training, standard language intervention; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 21 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: UMEC/VI DPI, Placebo DPI, Albuterol/salbutamol MDI; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years and older
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 10
States / cities: Jasper, Alabama • Saint Charles, Missouri • Charlotte, North Carolina + 7 more

Conditions: Type 2 Diabetes Mellitus
Interventions: GlucoType; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 2
States / cities: New York, New York

Conditions: Alzheimer Disease, Hearing Loss, Cognitive Impairment
Interventions: Hearing Intervention, Health Education Intervention; Device · Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 55 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Weight Loss, Weight Gain, Eating Behavior, Obesity, Bariatric Surgery Candidate
Interventions: Mindfulness Orientated Recovery Enhancement, Control Intervention; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Search by objective public record fields.

A Trial of Self-Adjusted Nitrous Versus Placebo During Office Vasectomy

A Media Based Motivational Intervention to Prevent Alcohol Exposed Pregnancies (AEPs)

Migraine in Adolescents

Component Analysis for Motivational Interviewing

Addressing Mental Health Disparities in Refugee Children

Testing the Efficacy of a Spousal Support Enhanced Weight Loss Program on Weight Loss Among African American Men

Step-Up Intervention for Self-Management of Fatigue in Young Adults Receiving Chemotherapy

Right For Me: Birth Control Decisions Made Easier

Self Regulated Physical Activity and Bone Growth Enhancement in Premature Infants

Care Expansion Across Remote Environments - Sub-Study of the SELF-GYN1 Trial

A Cognitive Behavioral Stress Intervention for Women Who Smoke

Adolescent Interventions to Manage Self-regulation of T1D (AIMS T1D)

Evaluating the Efficacy of Pathways Parent-Mediated Early Autism Intervention on Social Attention and Language

Real Time fMRI and Quitting Smoking

Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors

National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring With Data Sharing in Older Adults With Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.

Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence

A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications

Enhancing Language Function in Aphasia

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Personalizing Self-management in Diabetes - Pilot Study

Early Age-Related Hearing Loss Investigation (EARHLI)

Eating Mindfully to Prevent Weight Regain